Firas Almazedi

492 total citations · 1 hit paper
2 papers, 335 citations indexed

About

Firas Almazedi is a scholar working on Infectious Diseases, Molecular Biology and Pharmacology. According to data from OpenAlex, Firas Almazedi has authored 2 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Infectious Diseases, 1 paper in Molecular Biology and 1 paper in Pharmacology. Recurrent topics in Firas Almazedi's work include Viral gastroenteritis research and epidemiology (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). Firas Almazedi is often cited by papers focused on Viral gastroenteritis research and epidemiology (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). Firas Almazedi collaborates with scholars based in United Kingdom, Denmark and United States. Firas Almazedi's co-authors include Wayne Holman, Wendy Painter, George R. Painter, Jim Bush, Laura J. Szewczyk, Merribeth J. Morin, Cristina Boschini, Tine A. Bækdal, Ashley Brooks and Kirsten Dahl and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy and Diabetes Obesity and Metabolism.

In The Last Decade

Firas Almazedi

2 papers receiving 324 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2

2021 274 citations Wendy Painter, Wayne Holman et al. Antimicrobial Agents and Chemotherapy profile →

Peers

Countries citing papers authored by Firas Almazedi

Since Specialization

Citations

This map shows the geographic impact of Firas Almazedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Firas Almazedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Firas Almazedi more than expected).

Fields of papers citing papers by Firas Almazedi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Firas Almazedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Firas Almazedi. The network helps show where Firas Almazedi may publish in the future.

Co-authorship network of co-authors of Firas Almazedi

This figure shows the co-authorship network connecting the top 25 collaborators of Firas Almazedi. A scholar is included among the top collaborators of Firas Almazedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Firas Almazedi. Firas Almazedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

#	Work	Indexed citations
1	Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2 breakdown → 2021 ·Antimicrobial Agents and Chemotherapy ·Wendy Painter, Wayne Holman, Jim Bush, Firas Almazedi, (unknown), (unknown), Merribeth J. Morin, Laura J. Szewczyk, George R. Painter	274
2	Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes 2021 ·Diabetes Obesity and Metabolism ·Kirsten Dahl, Ashley Brooks, Firas Almazedi, Søren T. Hoff, Cristina Boschini, Tine A. Bækdal	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact